Start2 Group Partners with BARDA for $100M Antiviral Prize Competition Start2 Group announces a collaboration with BARDA to launch a $100 million prize competition aimed at developing broad-spectrum antiviral therapies, enhancing U.S. health security.

Start2 Group Partners with BARDA for $100M Antiviral Prize Competition #USA #Cambridge #BARDA #Start2_Group #Antiviral_Prize